International Society for the Study of Women's Sexual Health clinical practice guideline for the use of systemic testosterone for hypoactive sexual desire disorder in …

SJ Parish, JA Simon, SR Davis, A Giraldi… - The journal of sexual …, 2021 - academic.oup.com
ABSTRACT Background The Global Consensus Position Statement on the Use of
Testosterone Therapy for Women (Global Position Statement) recommended testosterone …

Management of perimenopausal and menopausal symptoms

ER Duralde, TH Sobel, JAE Manson - bmj, 2023 - bmj.com
Most women worldwide experience menopausal symptoms during the menopause transition
or postmenopause. Vasomotor symptoms are most pronounced during the first four to seven …

The British Menopause Society & Women's Health Concern 2020 recommendations on hormone replacement therapy in menopausal women

H Hamoda, N Panay, H Pedder, R Arya… - Post reproductive …, 2020 - journals.sagepub.com
The British Menopause Society & Women’s Health Concern 2020 recommendations on
hormone replacement therapy in menopausal women - Haitham Hamoda, Nick Panay …

Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis

AR Neves, P Montoya-Botero, NP Polyzos - American journal of obstetrics …, 2022 - Elsevier
Objective This study aimed to present a narrative review regarding androgen production,
androgens' role in folliculogenesis, and the available therapeutic approaches for androgen …

Androgens in postmenopausal women: a review

JL Shifren, SR Davis - Menopause, 2017 - journals.lww.com
There is significant interest in the use of androgen therapy for postmenopausal women. This
review provides background on endogenous androgens in women, describes factors that …

The role of androgen supplementation in women with diminished ovarian reserve: time to randomize, not meta-analyze

AR Neves, P Montoya-Botero… - Frontiers in endocrinology, 2021 - frontiersin.org
The management of patients with diminished ovarian reserve (DOR) remains one of the
most challenging tasks in IVF clinical practice. Despite the promising results obtained from …

Androgen therapy for women after menopause

KI Marko, JA Simon - Best Practice & Research Clinical Endocrinology & …, 2021 - Elsevier
Background Androgens are essential hormones in women. Yet, androgen therapy is
understudied and underutilized despite showing improvement in postmenopausal …

Testosterone use in postmenopausal women

A Martínez-García, SR Davis - Climacteric, 2021 - Taylor & Francis
The physiological, clinical and therapeutic aspects of testosterone in women's health are still
a matter of controversy and debate. Quality evidence data of clinical trials favors the use of …

The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: a randomised, placebo-controlled, pilot study

B Golebiowski, N Badarudin, J Eden… - British Journal of …, 2017 - bjo.bmj.com
Aims Sex hormones could provide a future treatment avenue for dry eye post menopause.
However, there are few well-controlled studies. This study investigates the impact of …

Does transdermal testosterone increase the risk of developing breast cancer? A systematic review

R Gera, S Tayeh, HEH Chehade… - Anticancer Research, 2018 - ar.iiarjournals.org
Background/Aim: Hypoactive sexual desire disorder (HSDD) is hypothesised to manifest in
postmenopausal women at onset of menopause due to decreased oestrogen levels …